The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera

Polycythemia vera (PV) is a chronic myeloproliferative disorder whose major morbidity and mortality are thrombohaemorragic events. Current guidelines advise maintaining hematocrit (HCT) level below 45% in males and 42% in females. Such targets lean on pathophysiological reasoning, while evidence fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchioli, Roberto, Finazzi, Guido, Specchia, Giorgina, Masciulli, Arianna, Mennitto, Maria Rosaria, Barbui, Tiziano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200258/
https://www.ncbi.nlm.nih.gov/pubmed/22084668
http://dx.doi.org/10.1155/2011/794240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200258/
https://www.ncbi.nlm.nih.gov/pubmed/22084668
http://dx.doi.org/10.1155/2011/794240

Ejemplares similares